(2'S,2R,trans)-Saxagliptin is an impurity of Saxagliptin (BMS477118; BMS-477118; Onglyza), which is a DPP-4 (dipeptidyl peptidase-4) inhibitor approved in 2008 by FDA for the treatment of type 2 diabetes.

纯度：≥98%

CAS：1564266-00-7